Related Experiment Videos
Fixed-Dose Combinations for Hypertension: Barriers to Use and Opportunities for Health Systems
Pranay Narang1,2, Josselyne Marquez3, Neema Rashidi1
1University of California, Berkeley, University of California, San Francisco Joint Medical Program, Berkeley, California, USA.
Insights
Fixed-dose combinations (FDCs) for hypertension are underutilized due to systemic barriers and provider misconceptions. Implementing targeted educational and system-level changes can improve FDC adoption and patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Health Services Research
- Pharmacology
Background:
- Uncontrolled hypertension significantly contributes to severe cardiovascular and renal diseases.
- Fixed-dose combinations (FDCs) are recommended for hypertension management to enhance adherence and efficacy.
- Despite guidelines, FDC use is low in U.S. health systems, with limited research on barriers.
Purpose of the Study:
- To identify structural and provider-level barriers to fixed-dose combination (FDC) utilization in hypertension management.
- To develop stakeholder-informed recommendations for increasing FDC uptake in health systems.
Main Methods:
- Conducted semi-structured interviews with healthcare providers, population health stakeholders, and health system executives.
- Utilized thematic analysis to identify barriers and inform recommendations for FDC utilization.
Main Results:
- Identified structural barriers: limited training exposure, ingrained monotherapy culture, workflow issues, fragmented formularies, and lack of incentives/endorsements.
- Clinicians reported low FDC use and concerns about dosage flexibility, contrasting with pharmacists and NPs who recognized FDC benefits.
- Discrepancies in FDC familiarity and perceived advantages highlight a gap between provider groups.
Conclusions:
- Integrate FDC education into medical and pharmacy curricula.
- Implement electronic health record decision support for FDCs.
- Expand team-based care models for medication management.
- Secure leadership support, create provider incentives, and establish tracking mechanisms.
- Promote FDC adoption through champions, continuing education, and socialization.
Background:
Uncontrolled hypertension is a leading driver of heart disease, chronic kidney disease, heart failure, dementia, stroke, and pregnancy-related complications. Fixed-dose combinations (FDCs) are guideline-endorsed first-line therapies that improve blood pressure control by reducing pill burden, improving adherence, and targeting multiple pathophysiological mechanisms. However, FDC utilization remains low across U.S. health systems. Few studies examine the factors influencing FDC uptake; existing qualitative studies rarely interrogate structural barriers or formulate stakeholder-informed recommendations.
Methods:
We explored the perspectives of providers, population health stakeholders, and health system executives through semi-structured interviews/thematic analysis to identify structural and provider-level barriers to FDC utilization and formulate recommendations for health systems.
Results:
Structural barriers included low exposure to FDCs early in training, entrenched monotherapy-reliant cultures, workflow constraints, fragmented formularies, and absent performance incentives and leadership endorsements. Provider-level perspectives and practices diverged: clinicians reported minimal use of FDCs, limited familiarity with FDCs, and concerns about dosage inflexibility and adverse effects. By contrast, pharmacists and nurse practitioners identified as major proponents of FDCs, demonstrated broad familiarity with therapeutic and cost advantages, and reframed clinicians concerns as misconceptions due to limited exposure.
Conclusions:
To improve FDC utilization, we propose: (1) integrating FDC exposure into early medical and pharmacy curricula; (2) embedding decision-support tools and SmartSets that prompt FDC consideration into electronic medical records; (3) expanding team-based care models to distribute responsibility for medication intensification; (4) securing leadership endorsements, novel incentive structures for providers, and data tracking mechanisms; and (5) fostering normative change through champions, CME-accredited workshops, and socialization strategies.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Dosage Regimens: Designs and Approaches
Drug Dosing: Obese Patients
Dosage Regimen: Individualization
Oral Drug Delivery Systems: Continuous-Release Systems